Cairn Diagnostics

About Cairn Diagnostics

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• PR Newswire · 2026-10-03
  Cairn Diagnostics announces Phase II readout for lead theranostic candidate
  The work builds on more than a decade of radiochemistry collaboration.
• Nuclear Medicine Today · 2026-09-08
  Cairn Diagnostics expands cyclotron capacity to meet Lu-177 demand
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• STAT News · 2026-12-01
  Cairn Diagnostics signs supply agreement to support late-stage trials
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Imaging Wire · 2026-07-10
  Cairn Diagnostics appoints new Chief Medical Officer ahead of pivotal trial
  The announcement comes amid tightening Mo-99 and Lu-177 supply.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.